Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy.

Details

Language :

English

ISSN :

0732183X

Volume :

30

Issue :

6

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

71739082

Full Text :

https://doi.org/10.1200/JCO.2011.37.4223